MT Newswires on MSN23m
Amgen Obesity Drug Falls Short of Efficacy Expectations in Trial, Mizuho Says; Shares Decline
Shares of Amgen (AMGN) fell on Tuesday after the biotech company reported results for a phase 2 study of its obesity injection, which fell short of efficacy expectations, Mizuho Securities said. Amgen ...
3bmedianews35m
TENNCARE REQUESTING $118 MILLION FOR POPULAR TYPE 2 DIABETES DRUGS
In a recent budget meeting the Tennessee Department of Finance and Administration’s Division of TennCare made some requests ...